about
Ursodeoxycholic acid reduces increased circulating endothelin 2 in primary biliary cirrhosisSerum response factor-GATA ternary complex required for nuclear signaling by a G-protein-coupled receptorEndothelin receptors as novel targets in tumor therapyThe endothelin axis: emerging role in cancerSmall bioactive peptides and cell surface peptidases in androgen-independent prostate cancer.A cytokine reborn? Endothelin-1 in pulmonary inflammation and fibrosis.Anti-endothelin drugs in solid tumors.Quantitative morphodynamics of endothelial cells within confluent cultures in response to fluid shear stressMacitentan (ACT-064992), a tissue-targeting endothelin receptor antagonist, enhances therapeutic efficacy of paclitaxel by modulating survival pathways in orthotopic models of metastatic human ovarian cancer.Endothelin receptor expression and pharmacology in human saphenous vein graft.The endothelin system in Morris hepatoma-7777: an endothelin receptor antagonist inhibits growth in vitro and in vivoPulmonary artery adventitial fibroblasts cooperate with vasa vasorum endothelial cells to regulate vasa vasorum neovascularization: a process mediated by hypoxia and endothelin-1.Transcriptional alterations of ET-1 axis and DNA damage in lung tissue of a rat obesity model.Transforming growth factor-beta 1 hyperexpression in African-American hypertensives: A novel mediator of hypertension and/or target organ damage.Modulation and roles of the endothelins in the pathophysiology of pulmonary embolism.Endothelin-1 stimulates human colonic myofibroblast contraction and migrationGrowth inhibitory properties of endothelin-1 in human hepatic myofibroblastic Ito cells. An endothelin B receptor-mediated pathwayExpression and localization of endothelin-1 and endothelin receptors in human meningiomas. Evidence for a role in tumoral growthRepeatability of local forearm vasoconstriction to endothelin-1 measured by venous occlusion plethysmographyThe autonomous growth of human papillomavirus type 16-immortalized keratinocytes is related to the endothelin-1 autocrine loop.Atrasentan: targeting the endothelin axis in prostate cancer.Human breast cancer cells contain a phosphoramidon-sensitive metalloproteinase which can process exogenous big endothelin-1 to endothelin-1: a proposed mitogen for human breast fibroblasts.Specific inhibition of the endothelin A receptor with ZD4054: clinical and pre-clinical evidence.Cardiopulmonary indications for endothelin receptor antagonists: review of recent efficacy trials.Atrasentan: a novel and rationally designed therapeutic alternative in the management of cancer.Neuropeptide-inducible upregulation of proteasome activity precedes nuclear factor kappa B activation in androgen-independent prostate cancer cells.The endothelin axis in urologic tumors: mechanisms of tumor biology and therapeutic implications.Neurotransmitter receptor expression and activity during neuronal differentiation of embryonal carcinoma and stem cells: from basic research towards clinical applications.Endothelin and endothelin receptor antagonism in portopulmonary hypertension.Epithelial-mesenchymal transition in ovarian cancer progression: a crucial role for the endothelin axis.New and emerging therapies for bone metastases in genitourinary cancers.Emerging therapies to prevent skeletal morbidity in men with prostate cancer.Endothelin receptor antagonists in cancer therapy.Phase I safety study of escalating doses of atrasentan in adults with recurrent malignant glioma.Stromal endothelin B receptor-deficiency inhibits breast cancer growth and metastasis.Endothelin antagonism in experimental hepatic fibrosis. Implications for endothelin in the pathogenesis of wound healing.Growth inhibitory properties of endothelin-1 in activated human hepatic stellate cells: a cyclic adenosine monophosphate-mediated pathway. Inhibition of both extracellular signal-regulated kinase and c-Jun kinase and upregulation of endothelin B recMyocardial protective effect of tezosentan, an endothelin receptor antagonist, for ischemia-reperfusion injury in experimental heart failure models.Endothelin-converting enzyme-1 (ECE-1) is post-transcriptionally regulated by alternative polyadenylationZibotentan for the treatment of castrate-resistant prostate cancer.
P2860
Q24293659-D89FEFCB-14E1-4192-9351-38056B336275Q24548383-9F1A9628-4EAD-4A5F-84C5-CF00FC5C364FQ24797288-1EACBB5B-C941-453E-A5B8-73DCC2112A95Q28206793-32A1668E-C44D-405B-A37E-9FE3F31E4B03Q33853729-BE90BA47-8FC6-4198-AE80-E91DE2CD1B16Q33954012-8438DF42-7732-4D08-B74B-95F7ADF744D0Q34021011-FAB8F9B0-AC17-4FD9-87F3-2EF4014D322FQ34173798-7C6AA85D-B064-4EFD-8C38-7E956DEAABABQ34551567-6175B2E8-26D1-4638-85B5-FE1E818BF335Q35028439-DBBC87C5-6DFE-42B9-8593-1D584A6889FCQ35046058-A1F41201-702C-4205-BB36-663E8E0F4DBAQ35088354-0D0D1EE0-B55F-41BA-AF63-62308B4A11B2Q35110780-BDF06A17-A1AE-4772-93DA-214939686602Q35113482-D8A63D97-EA6C-429B-9F7D-673457D0E2D8Q35168407-82BD606F-1200-4468-B862-F84ABB5F470DQ35594307-BB3B4FDD-DE14-4AB0-A45D-02A710FEACB9Q35749916-68867B4F-6D38-4C83-87BB-9B6833CC6899Q35765074-FFE18B0C-B6DA-428A-8667-545F56036C0DQ35804085-877E0B04-7D87-4AB4-9091-C17DF464C6AFQ35892290-5BB3F7F5-4BE2-4C54-B5C2-6AA302FE926DQ35964727-1FB70082-C705-4E88-B096-ED1233195C78Q36080476-A83D5D2D-5AF8-4152-A738-F87236B3D71FQ36163574-0DC4ACA1-FC36-4E98-9F2F-8884AC0F97FDQ36179755-7AC8467B-8FDC-40A7-A6CB-3DA375C6084CQ36185608-3498D888-2E7F-4CC4-91AD-3E6E8EC44AF9Q36233076-5AB0C236-1B2D-494C-9B56-AE69634A8A88Q36352082-4589C106-4FC5-4305-B4E8-09233916648FQ36548773-A2B35CE6-E3D8-4550-ABD4-96420A1F47AFQ36570852-CB023F19-26C5-49F0-9765-460732E30657Q36857782-88A11F60-4E52-4187-A1F5-E2FF8A6BD154Q36866291-5078BB34-5E4D-496C-9E2F-D1CF3C813653Q36910469-789F2EEC-8726-4D24-9E97-B5A124DF94D2Q37024077-9667EC9F-6D80-446A-8BD0-CEC85E98480BQ37152004-F3042D22-8840-4C04-BBD3-423DADC4575DQ37310022-29523EAC-F432-4DC6-8796-FB2B05BD9DB2Q37359804-D77B9673-1B64-4C92-899C-31047BF6E1B7Q37362152-ECA50301-6B32-4589-A42C-093F47E9FC6CQ37364486-ABEBD2B2-A389-4D68-85FB-F0741B0B6D91Q37537948-C45C708C-6347-4ED8-BA11-DE05E769294AQ37760222-1FFF24C9-1B04-4217-B098-A7AA2C8070FE
P2860
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Growth regulatory properties of endothelins.
@en
type
label
Growth regulatory properties of endothelins.
@en
prefLabel
Growth regulatory properties of endothelins.
@en
P2093
P1433
P1476
Growth regulatory properties of endothelins.
@en
P2093
Battistini B
Chailler P
D'Orléans-Juste P
P304
P356
10.1016/0196-9781(93)90057-N
P577
1993-03-01T00:00:00Z